Literature DB >> 28423320

Sequence and Structural Analyses Reveal Distinct and Highly Diverse Human CD8+ TCR Repertoires to Immunodominant Viral Antigens.

Guobing Chen1, Xinbo Yang2, Annette Ko1, Xiaoping Sun1, Mingming Gao2, Yongqing Zhang3, Alvin Shi1, Roy A Mariuzza2, Nan-Ping Weng4.   

Abstract

A diverse T cell receptor (TCR) repertoire is essential for controlling viral infections. However, information about TCR repertoires to defined viral antigens is limited. We performed a comprehensive analysis of CD8+ TCR repertoires for two dominant viral epitopes: pp65495-503 (NLV) of cytomegalovirus and M158-66 (GIL) of influenza A virus. The highly individualized repertoires (87-5,533 α or β clonotypes per subject) comprised thousands of unique TCRα and TCRβ sequences and dozens of distinct complementary determining region (CDR)3α and CDR3β motifs. However, diversity is effectively restricted by preferential V-J combinations, CDR3 lengths, and CDR3α/CDR3β pairings. Structures of two GIL-specific TCRs bound to GIL-HLA-A2 provided a potential explanation for the lower diversity of GIL-specific versus NLV-specific repertoires. These anti-viral TCRs occupied up to 3.4% of the CD8+ TCRβ repertoire, ensuring broad T cell responses to single epitopes. Our portrait of two anti-viral TCR repertoires may inform the development of predictors of immune protection.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  CD8 T cells; TCR repertoire; TCR-pMHC structure; human; αβ TCRs for CMV-NLV; αβ TCRs for IAV-GIL

Mesh:

Substances:

Year:  2017        PMID: 28423320      PMCID: PMC5472051          DOI: 10.1016/j.celrep.2017.03.072

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  58 in total

1.  A structural basis for the selection of dominant alphabeta T cell receptors in antiviral immunity.

Authors:  Lars Kjer-Nielsen; Craig S Clements; Anthony W Purcell; Andrew G Brooks; James C Whisstock; Scott R Burrows; James McCluskey; Jamie Rossjohn
Journal:  Immunity       Date:  2003-01       Impact factor: 31.745

Review 2.  TCR clonotypes: molecular determinants of T-cell efficacy against HIV.

Authors:  Anna Lissina; Lisa A Chakrabarti; Masafumi Takiguchi; Victor Appay
Journal:  Curr Opin Virol       Date:  2016-02-12       Impact factor: 7.090

3.  In vitro expansion of antigen-specific CD8(+) T cells distorts the T-cell repertoire.

Authors:  Dan Koning; Ana I Costa; Raiza Hasrat; Bart P X Grady; Sanne Spijkers; Nening Nanlohy; Can Keşmir; Debbie van Baarle
Journal:  J Immunol Methods       Date:  2014-02-07       Impact factor: 2.303

4.  Overlap and effective size of the human CD8+ T cell receptor repertoire.

Authors:  Harlan S Robins; Santosh K Srivastava; Paulo V Campregher; Cameron J Turtle; Jessica Andriesen; Stanley R Riddell; Christopher S Carlson; Edus H Warren
Journal:  Sci Transl Med       Date:  2010-09-01       Impact factor: 17.956

5.  Recognition of distinct cross-reactive virus-specific CD8+ T cells reveals a unique TCR signature in a clinical setting.

Authors:  Thi H O Nguyen; Louise C Rowntree; Daniel G Pellicci; Nicola L Bird; Andreas Handel; Lars Kjer-Nielsen; Katherine Kedzierska; Tom C Kotsimbos; Nicole A Mifsud
Journal:  J Immunol       Date:  2014-04-28       Impact factor: 5.422

Review 6.  Structural basis for self-recognition by autoimmune T-cell receptors.

Authors:  Yiyuan Yin; Yili Li; Roy A Mariuzza
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

7.  Genetic and structural basis for selection of a ubiquitous T cell receptor deployed in Epstein-Barr virus infection.

Authors:  John J Miles; Anna M Bulek; David K Cole; Emma Gostick; Andrea J A Schauenburg; Garry Dolton; Vanessa Venturi; Miles P Davenport; Mai Ping Tan; Scott R Burrows; Linda Wooldridge; David A Price; Pierre J Rizkallah; Andrew K Sewell
Journal:  PLoS Pathog       Date:  2010-11-18       Impact factor: 6.823

Review 8.  CD8(+) T cells: foot soldiers of the immune system.

Authors:  Nu Zhang; Michael J Bevan
Journal:  Immunity       Date:  2011-08-26       Impact factor: 31.745

9.  Naive CD8⁺ T-cell precursors display structured TCR repertoires and composite antigen-driven selection dynamics.

Authors:  Michelle A Neller; Kristin Ladell; James E McLaren; Katherine K Matthews; Emma Gostick; Johanne M Pentier; Garry Dolton; Andrea J A Schauenburg; Dan Koning; Ana Isabel C A Fontaine Costa; Thomas S Watkins; Vanessa Venturi; Corey Smith; Rajiv Khanna; Kelly Miners; Mathew Clement; Linda Wooldridge; David K Cole; Debbie van Baarle; Andrew K Sewell; Scott R Burrows; David A Price; John J Miles
Journal:  Immunol Cell Biol       Date:  2015-03-24       Impact factor: 5.126

Review 10.  Why must T cells be cross-reactive?

Authors:  Andrew K Sewell
Journal:  Nat Rev Immunol       Date:  2012-09       Impact factor: 53.106

View more
  45 in total

1.  Bacterial Superantigens Expand and Activate, Rather than Delete or Incapacitate, Preexisting Antigen-Specific Memory CD8+ T Cells.

Authors:  Courtney E Meilleur; Christine M Wardell; Tina S Mele; Jimmy D Dikeakos; Jack R Bennink; Hong-Hua Mu; John K McCormick; S M Mansour Haeryfar
Journal:  J Infect Dis       Date:  2019-04-08       Impact factor: 5.226

Review 2.  The impact of inflationary cytomegalovirus-specific memory T cells on anti-tumour immune responses in patients with cancer.

Authors:  Xiao-Hua Luo; Qingda Meng; Martin Rao; Zhenjiang Liu; Georgia Paraschoudi; Ernest Dodoo; Markus Maeurer
Journal:  Immunology       Date:  2018-09-10       Impact factor: 7.397

3.  TCRs with Distinct Specificity Profiles Use Different Binding Modes to Engage an Identical Peptide-HLA Complex.

Authors:  Charlotte H Coles; Rachel M Mulvaney; Sunir Malla; Andrew Walker; Kathrine J Smith; Angharad Lloyd; Kate L Lowe; Michelle L McCully; Ruth Martinez Hague; Milos Aleksic; Jane Harper; Samantha J Paston; Zoe Donnellan; Fiona Chester; Katrin Wiederhold; Ross A Robinson; Andrew Knox; Andrea R Stacey; Joseph Dukes; Emma Baston; Sue Griffin; Bent K Jakobsen; Annelise Vuidepot; Stephen Harper
Journal:  J Immunol       Date:  2020-02-26       Impact factor: 5.422

Review 4.  Emerging Concepts in TCR Specificity: Rationalizing and (Maybe) Predicting Outcomes.

Authors:  Nishant K Singh; Timothy P Riley; Sarah Catherine B Baker; Tyler Borrman; Zhiping Weng; Brian M Baker
Journal:  J Immunol       Date:  2017-10-01       Impact factor: 5.422

5.  Structural basis for clonal diversity of the human T-cell response to a dominant influenza virus epitope.

Authors:  Xinbo Yang; Guobing Chen; Nan-Ping Weng; Roy A Mariuzza
Journal:  J Biol Chem       Date:  2017-09-20       Impact factor: 5.157

6.  Deep learning-based prediction of the T cell receptor-antigen binding specificity.

Authors:  Tianshi Lu; Ze Zhang; James Zhu; Yunguan Wang; Peixin Jiang; Xue Xiao; Chantale Bernatchez; John V Heymach; Don L Gibbons; Jun Wang; Lin Xu; Alexandre Reuben; Tao Wang
Journal:  Nat Mach Intell       Date:  2021-09-23

7.  Public and private human T-cell clones respond differentially to HCMV antigen when boosted by CD3 copotentiation.

Authors:  Laura R E Becher; Wendy K Nevala; Shari Lee Sutor; Megan Abergel; Michele M Hoffmann; Christopher A Parks; Larry R Pease; Adam G Schrum; Svetomir N Markovic; Diana Gil
Journal:  Blood Adv       Date:  2020-11-10

8.  Backbone Modifications of HLA-A2-Restricted Antigens Induce Diverse Binding and T Cell Activation Outcomes.

Authors:  Ruslan Gibadullin; Caleb J Randall; John Sidney; Alessandro Sette; Samuel H Gellman
Journal:  J Am Chem Soc       Date:  2021-04-21       Impact factor: 15.419

9.  A framework for highly multiplexed dextramer mapping and prediction of T cell receptor sequences to antigen specificity.

Authors:  Wen Zhang; Peter G Hawkins; Jing He; Namita T Gupta; Jinrui Liu; Gabrielle Choonoo; Se W Jeong; Calvin R Chen; Ankur Dhanik; Myles Dillon; Raquel Deering; Lynn E Macdonald; Gavin Thurston; Gurinder S Atwal
Journal:  Sci Adv       Date:  2021-05-14       Impact factor: 14.136

10.  Expansion of Unique Hepatitis C Virus-Specific Public CD8+ T Cell Clonotypes during Acute Infection and Reinfection.

Authors:  Sabrina Mazouz; Maude Boisvert; Mohamed S Abdel-Hakeem; Omar Khedr; Julie Bruneau; Naglaa H Shoukry
Journal:  J Immunol       Date:  2021-08-02       Impact factor: 5.426

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.